News
03-02-2016, 06:21 PM
A combination of two drugs delays progression of advanced, aggressive breast cancer by an average of nine months - working in all subsets of the most common type of breast cancer.
More... (http://www.medicalnewstoday.com/releases/307324.php)
More... (http://www.medicalnewstoday.com/releases/307324.php)